These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 15325472)

  • 1. Neuroendocrine evaluation of cardiac disease.
    Sisson DD
    Vet Clin North Am Small Anim Pract; 2004 Sep; 34(5):1105-26. PubMed ID: 15325472
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of acute congestive heart failure in dogs and cats: 145 cases (2007-2008).
    Goutal CM; Keir I; Kenney S; Rush JE; Freeman LM
    J Vet Emerg Crit Care (San Antonio); 2010 Jun; 20(3):330-7. PubMed ID: 20636986
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Utility of plasma N-terminal pro-brain natriuretic peptide (NT-proBNP) to distinguish between congestive heart failure and non-cardiac causes of acute dyspnea in cats.
    Fox PR; Oyama MA; Reynolds C; Rush JE; DeFrancesco TC; Keene BW; Atkins CE; Macdonald KA; Schober KE; Bonagura JD; Stepien RL; Kellihan HB; Nguyenba TP; Lehmkuhl LB; Lefbom BK; Moise NS; Hogan DF
    J Vet Cardiol; 2009 May; 11 Suppl 1():S51-61. PubMed ID: 19394287
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Angiotensin-converting enzyme inhibitors in the therapy of renal diseases.
    Lefebvre HP; Toutain PL
    J Vet Pharmacol Ther; 2004 Oct; 27(5):265-81. PubMed ID: 15500563
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Activation of the renin-angiotensin-aldosterone system in heart failure].
    Volpe M; Tocci G; Pagannone E
    Ital Heart J; 2005 May; 6 Suppl 1():16S-23S. PubMed ID: 15945296
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determinants of increased angiotensin II levels in severe chronic heart failure patients despite ACE inhibition.
    van de Wal RM; Plokker HW; Lok DJ; Boomsma F; van der Horst FA; van Veldhuisen DJ; van Gilst WH; Voors AA
    Int J Cardiol; 2006 Jan; 106(3):367-72. PubMed ID: 16337046
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of angiotensin-converting enzyme inhibition on plasma aldosterone concentration, plasma renin activity, and blood pressure in spontaneously hypertensive cats with chronic renal disease.
    Steele JL; Henik RA; Stepien RL
    Vet Ther; 2002; 3(2):157-66. PubMed ID: 19750747
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Measurement of N-terminal proatrial natriuretic peptide in plasma of cats with and without cardiomyopathy.
    Zimmering TM; Meneses F; Nolte IJ; Simon D
    Am J Vet Res; 2009 Feb; 70(2):216-22. PubMed ID: 19231954
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of the diagnostic accuracy of circulating natriuretic peptide concentrations to distinguish between cats with cardiac and non-cardiac causes of respiratory distress.
    Connolly DJ; Soares Magalhaes RJ; Fuentes VL; Boswood A; Cole G; Boag A; Syme HM
    J Vet Cardiol; 2009 May; 11 Suppl 1():S41-50. PubMed ID: 19394286
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Natriuretic peptides--new diagnostic markers in heart disease].
    Angermann CE; Ertl G
    Herz; 2004 Sep; 29(6):609-17. PubMed ID: 15912436
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiac troponin I is elevated in dogs and cats with azotaemia renal failure and in dogs with non-cardiac systemic disease.
    Porciello F; Rishniw M; Herndon WE; Birettoni F; Antognoni MT; Simpson KW
    Aust Vet J; 2008 Oct; 86(10):390-4. PubMed ID: 18826510
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biomarkers for differentiation of causes of respiratory distress in dogs and cats: Part 1--Cardiac diseases and pulmonary hypertension.
    Smith KF; Quinn RL; Rahilly LJ
    J Vet Emerg Crit Care (San Antonio); 2015; 25(3):311-29. PubMed ID: 26040814
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The diagnostic accuracy of different natriuretic peptides in the investigation of canine cardiac disease.
    Boswood A; Dukes-McEwan J; Loureiro J; James RA; Martin M; Stafford-Johnson M; Smith P; Little C; Attree S
    J Small Anim Pract; 2008 Jan; 49(1):26-32. PubMed ID: 18005104
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardioprotection by aldosterone receptor antagonism in heart failure. Part I. The role of aldosterone in heart failure.
    Dieterich HA; Wendt C; Saborowski F
    Fiziol Cheloveka; 2005; 31(6):97-105. PubMed ID: 16366159
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of plasma cardiac troponin I concentration as a means to differentiate cardiac and noncardiac causes of dyspnea in cats.
    Herndon WE; Rishniw M; Schrope D; Sammarco CD; Boddy KN; Sleeper MM
    J Am Vet Med Assoc; 2008 Oct; 233(8):1261-4. PubMed ID: 18922052
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beta-blockade in the management of systolic dysfunction.
    Abbott JA
    Vet Clin North Am Small Anim Pract; 2004 Sep; 34(5):1157-70. PubMed ID: 15325475
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biomarkers in cardiovascular disease: beyond natriuretic peptides.
    Boswood A
    J Vet Cardiol; 2009 May; 11 Suppl 1():S23-32. PubMed ID: 19395333
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of pimobendan in the management of heart failure.
    Fuentes VL
    Vet Clin North Am Small Anim Pract; 2004 Sep; 34(5):1145-55. PubMed ID: 15325474
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neurohormonal activation in congestive heart failure and the role of vasopressin.
    Chatterjee K
    Am J Cardiol; 2005 May; 95(9A):8B-13B. PubMed ID: 15847852
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of the oral direct renin inhibitor aliskiren in patients with symptomatic heart failure.
    McMurray JJ; Pitt B; Latini R; Maggioni AP; Solomon SD; Keefe DL; Ford J; Verma A; Lewsey J;
    Circ Heart Fail; 2008 May; 1(1):17-24. PubMed ID: 19808266
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.